Granules India Q1FY22 results are out and it marks a robust, sustainable growth path. Granules is a vertically integrated fast-growing Indian pharmaceutical company headquartered in Hyderabad with best in class facilities and commitment to operational excellence, quality, and customer service has announced sustainable growth despite the pandemic challenges.
Commenting on the results, Mr. Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India Limited said, “The last quarter was full of learnings and challenges both in terms of business and battling the pandemic. The business was temporarily impacted, and actions were taken to get it back on track. This testing time had given us an opportunity to think and plan to empower our future in a sustainable and reliable manner.
Granules India Results Business Highlights for Q1FY22
- Income from operations up 16% YoY, despite challenges faced by a shortage of raw materials, lower utilization capacities especially in Paracetamol, and logistic disruptions. Non-receipt of MEIS benefits also impacted the total income. However, the growth was driven by new launches and increased market share for existing products.
- EBITDA for the quarter stood at INR 201 Cr, up 10% YoY due to sales increase, mainly in North America.
- PAT for the quarter stood at INR 120 Cr, up 8% YoY.
- During the quarter, we filed one ANDA, two EU dossiers, one UK dossier, and one South African dossier. We received one ANDA approval and launched one ANDA in the US
- The pharmaceutical Formulation Intermediates (PFI) segment grew 25% YoY, the Active Pharmaceutical Ingredients (API) segment grew 5% YoY and the Finished Dosage (FD) grew 18% YoY in terms of value.
- The Board of Directors has declared its first interim dividend of 25 paise per equity share of INR 1/- each.
#Granules : Financial Results For the Quarter Ended June 30, 2021 pic.twitter.com/2XmhJ4G7nX
— Granules India (@GranulesIndia) July 27, 2021
“I am happy that we are getting over these difficult times and becoming stronger to carry out our aspirations. We are focusing on making our growth strategy more robust while taking a hard look at our product pipeline which is our growth engine. While remaining confident of our sustainable growth, efforts will be continued to formalize and follow an orbit-changing strategy. I remain confident of our future sustainable growth.” Krishna Prasad said
